Clopidogrel Bisulfate tablet bulk supplier for pharma manufacturers

Clopidogrel Bisulfate Tablet 75 mg, 300 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 75 mg, 300 mg

Reference Brands: Plavix(US & EU)

Clopidogrel bisulfate film-coated tablets at 75 mg for maintenance and 300 mg for loading doses. For importers, distributors, hospital pharmacies and tender buyers sourcing a generic oral P2Y12 antiplatelet medicine.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Clopidogrel Bisulfate Tablet? List it or send an offer →

Product Description:

Clopidogrel is an oral antiplatelet medicine of the thienopyridine group. It is a prodrug: the liver converts it, largely through CYP2C19, into an active metabolite that binds the P2Y12 receptor on platelets and stops ADP from activating them. The block is irreversible and lasts for the life of each platelet, around seven to ten days. This page lists film-coated tablets of clopidogrel bisulfate. The 75 mg tablet is the daily maintenance dose, and the 300 mg tablet exists for the single loading dose given when fast onset is needed.

Clopidogrel is used after a recent heart attack or ischaemic stroke and in peripheral arterial disease, to cut the chance of further atherothrombotic events. With aspirin it forms dual antiplatelet therapy after acute coronary syndromes and stenting. It appears on the WHO essential medicines list. Bleeding is the main risk, and it is usually paused several days before planned surgery. Poor CYP2C19 metabolisers respond weakly, and omeprazole or esomeprazole reduce activation, so labels advise against combining them.

Sourcing notes. The tablets are prescription-only and registered nationally, usually on a generic CTD or ACTD dossier with bioequivalence data. The bisulfate salt has more than one crystal form, so the dossier should name the polymorph and show it stays stable. The tablets are moisture-sensitive, and high-barrier aluminium blisters are common, which matters in zone IVb. Ask for a batch CoA, GMP certificate and CoPP, and confirm the 300 mg strength is registered where you sell. Quote strength, pack size and blister type.

Also known as: clopidogrel (Portuguese, French), Clopidogrel (German), клопидогрел (Russian), كلوبيدوغريل (Arabic), 氯吡格雷 (Chinese), クロピドグレル (Japanese), 클로피도그렐 (Korean).

Clopidogrel Bisulfate Tablet — third party manufacturing & bulk supply

Clopidogrel Bisulfate Tablet 75 mg, 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Clopidogrel Bisulfate Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Clopidogrel Bisulfate Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Clopidogrel Bisulfate Tablet →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Clopidogrel bisulfate is used to reduce the risk of heart attack and stroke in people with cardiovascular diseases such as recent myocardial infarction, recent stroke, or established peripheral arterial disease. It is also used in patients with acute coronary syndrome to prevent blood clots that can block blood vessels.

Clopidogrel bisulfate is a chemically synthesized antiplatelet agent. It is the bisulfate salt form of clopidogrel, which enhances the stability and bioavailability of the active substance in the body.

Clopidogrel bisulfate is marketed under several trade names globally, the most well-known being Plavix.

The original brand Plavix was developed and marketed by Sanofi and Bristol-Myers Squibb. Today, clopidogrel bisulfate is manufactured by multiple pharmaceutical companies worldwide as both branded and generic versions.

The generic name is clopidogrel bisulfate.

Common brand names include Plavix and various country-specific branded generics.

Clopidogrel bisulfate is manufactured in multiple countries, including the USA, EU nations, India, and other regions, by approved pharmaceutical manufacturers following regulatory standards.